HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
China
· Delayed Price · Currency is CNY 7.20
-0.01 (-0.14%)
Apr 25, 2025, 2:45 PM CST
SHA:600829 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 180.78 | 213.27 | 292.16 | 264.48 | 277.3 | 145.26 | Upgrade
|
| Depreciation & Amortization | 60.3 | 60.3 | 60.18 | 63.99 | 60.44 | 24.9 | Upgrade
|
| Other Amortization | 4.77 | 4.77 | 5.92 | 4.5 | 4.33 | 5.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.23 | -0.23 | 0.35 | 0.36 | -0.07 | -0.28 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.14 | 2.14 | 0.81 | 0.3 | 1.95 | 13.44 | Upgrade
|
| Loss (Gain) From Sale of Investments | -13.9 | -13.9 | -3.89 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 19.24 | 19.24 | 24.85 | -11.08 | 9.17 | - | Upgrade
|
| Other Operating Activities | 93.95 | 27.88 | 27.02 | 27.01 | 17.82 | 7.27 | Upgrade
|
| Change in Accounts Receivable | -10.6 | -10.6 | -228.88 | 0.7 | -292.96 | -435.16 | Upgrade
|
| Change in Inventory | 16.45 | 16.45 | -41.41 | 31.22 | 17.35 | 21.96 | Upgrade
|
| Change in Accounts Payable | -204.15 | -204.15 | 201.01 | -76.03 | -326.39 | 213.11 | Upgrade
|
| Operating Cash Flow | 149.01 | 115.44 | 332.99 | 307.33 | -233 | -9.22 | Upgrade
|
| Operating Cash Flow Growth | 318.92% | -65.33% | 8.35% | - | - | - | Upgrade
|
| Capital Expenditures | -7.57 | -8.04 | -23.48 | -6.42 | -12.24 | -13.97 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.18 | 0.15 | 0.26 | 0.55 | 0.69 | 1.27 | Upgrade
|
| Divestitures | - | - | - | - | - | 0.02 | Upgrade
|
| Other Investing Activities | - | - | -156.64 | - | - | - | Upgrade
|
| Investing Cash Flow | -7.39 | -7.89 | -179.86 | -5.87 | -11.55 | -12.67 | Upgrade
|
| Short-Term Debt Issued | - | 949.22 | 681.73 | 1,392 | 1,320 | 599.77 | Upgrade
|
| Total Debt Issued | 899.22 | 949.22 | 681.73 | 1,392 | 1,320 | 599.77 | Upgrade
|
| Short-Term Debt Repaid | - | -1,072 | -917.8 | -1,299 | -699 | -524 | Upgrade
|
| Long-Term Debt Repaid | - | -42.19 | -46.42 | -42.75 | -44.93 | - | Upgrade
|
| Total Debt Repaid | -1,164 | -1,114 | -964.22 | -1,342 | -743.93 | -524 | Upgrade
|
| Net Debt Issued (Repaid) | -265.05 | -165.05 | -282.49 | 50.12 | 575.74 | 75.77 | Upgrade
|
| Common Dividends Paid | -165.09 | -160.41 | -24.62 | -30.48 | -35.65 | -4.26 | Upgrade
|
| Other Financing Activities | 1.92 | - | 424.97 | 129.88 | -197.78 | - | Upgrade
|
| Financing Cash Flow | -428.22 | -325.46 | 117.86 | 149.51 | 342.31 | 71.51 | Upgrade
|
| Net Cash Flow | -286.6 | -217.92 | 270.99 | 450.97 | 97.76 | 49.61 | Upgrade
|
| Free Cash Flow | 141.44 | 107.39 | 309.5 | 300.91 | -245.24 | -23.19 | Upgrade
|
| Free Cash Flow Growth | 1028.07% | -65.30% | 2.85% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 1.40% | 1.07% | 2.98% | 3.12% | -2.63% | -0.29% | Upgrade
|
| Free Cash Flow Per Share | 0.24 | 0.18 | 0.53 | 0.52 | -0.42 | -0.04 | Upgrade
|
| Cash Income Tax Paid | 293.17 | 305.32 | 281.41 | 254.71 | 281.28 | 226.5 | Upgrade
|
| Levered Free Cash Flow | 107.34 | -16.66 | 366.86 | 406.36 | -152 | -40.48 | Upgrade
|
| Unlevered Free Cash Flow | 125.02 | 1.02 | 383.88 | 434.13 | -120.55 | -21.26 | Upgrade
|
| Change in Net Working Capital | 98.21 | 243.47 | -83.96 | -132.67 | 431.26 | 195.18 | Upgrade
|
Updated Oct 21, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.